Semaglutide binds with GLP-1 receptors in your digestive tract and brain to reduce appetite, slow down digestion, and regulate blood sugar levels
This personalization extends to the medications themselves
Vision and Medication Warnings Semaglutide links to rare nonarteritic anterior ischemic optic neuropathy (NAION), causing sudden painless vision loss (blurring/cloudiness) from optic nerve hypoperfusion
Disrupted intestinal permeability is closely associated with dysbiosis, and there is reason to think that repairing the mucosal barrier creates a more hospitable environment for a healthy microbial community
[27] demonstrated that GIP receptor neurons differ in their connectivity, transcriptomic profile, peripheral accessibility, and appetite-controlling mechanisms with vast heterogeneity of the central GIP receptor signalling axis and further studies are needed to clarify the effects of GIP pharmacology on feeding behavior
Evidence indicates regulation of glutamatergic transmission, AMPA receptor trafficking via PI3K-associated synaptic proteins, and metabolic substrate utilization in neural tissue preparations